Skip to content
RCMT

RCM TECHNOLOGIES, INC.

RCM TECHNOLOGIES, INC. Q1 FY2025 earnings call

May 10, 2025 · fiscal period ended 2025-03

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-05-10

Management highlights

Management Statement and Operational Highlights

  • Brad Vizi highlighted internal business strengthening, focus on next-generation leadership, RCM Health Care's strong start in 2025 with K-12 growth and HIM division pipeline. Life Sciences and Data Solutions had a 40% gross profit, 23% NOI contribution, and 6 new clients in 2025. Engineering divisions: Energy Services secured multiyear agreements, Process and Industrial advanced with Thermal Kinetics expansion, and Aerospace Group exceeded revenue and EBITDA objectives.
  • Kevin Miller reported consolidated results: Q1 2025 consolidated gross profit was $22.0 million, up 7.9% year-over-year; adjusted EBITDA was $7.8 million, up 14.4% year-over-year; adjusted EPS was $0.63, up 18.9% year-over-year. Accounts receivable DSO improved to 74 days, and net debt was reduced to $18.2 million.
View in transcript ↓

Segment performance

Segment Performance

  • Health Care: Q1 2025 gross profit was $12.2 million, growing 10.2% year-over-year. School revenue in Q1 2025 was $37.3 million, an increase of 16.7% year-over-year. Nonschool revenue, when adjusting for a reduced long-term Care Group, was $5.5 million (vs. $5.1 million year-over-year). Gross margin for Q1 2025 was 28.2% compared to 29.0% in Q1 2024.
  • Engineering: Q1 2025 gross profit was $6.2 million, a 12.4% year-over-year growth, marking the best engineering gross profit quarter in history. Gross margin was 19.2% in Q1 2025 compared to 23.4% in Q1 2024. Lower gross margin was due to pass-through construction revenue from EPC contracts and lower margin from the Aerospace group.
  • IT, Life Sciences and Data Solutions: Q1 2025 gross profit was $3.6 million, a 5.3% year-over-year decline. Gross margin was 39.7% in Q1 2025 compared to 37.0% in Q1 2024.
View in transcript ↓

Guidance

Guidance

  • Expect at least low double-digit growth in adjusted EBITDA throughout fiscal 2025.
  • Anticipate Q4 2025 to be the highest adjusted EBITDA quarter of the year.
View in transcript ↓

Risks

Risks

  • No specific risks related to political policy uncertainty impacting business were discussed; Brad Vizi stated the macroeconomic environment is not a concern, and the business leverages secular themes.
View in transcript ↓

Q&A highlights

Question and Answer

  • Q: Is political policy uncertainty moving into the business or a concern? A: Brad Vizi responded that the macroeconomic environment is not a concern, and the business leverages secular themes to navigate potential impacts.
  • Q: Health care gross margin delta? A: Kevin Miller stated it was quarterly noise, with a mix shift in nursing contracts having lower gross margin, and expected Q2 to be better than Q1
View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

May 10, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.